Clonazepam

Related products

• 

  Familial spastic paraplegia

  Botulinum toxin

  【Product name】XEOMIN

  [English common name]incobotulinumtoxinA

  [Chinese common name]Botulinum toxin

  [English name]BTX, Botulinum Toxin

  [Chinese other name]Net good, angel bot

  [Indications] Eyelids, hemifacial spasms and related disorders of dystonia.

  [Usage and Dosage] The recommended dose of this product should not be interchanged with the dose of other Clostridium botulinum toxin preparations. This product must be used by a physician with appropriate qualifications and experience in treatment, and with appropriate equipment. The optimal effective dose and the optimal number of injection sites per muscle have not yet been established, so individual treatment regimens should be developed by the physician and the optimal dose should be determined by titration. Ailigen will assist in the training of this product injection technology. The recommended dose range for each injection site is 0.05-0.1 ml (eyelid, hemifacial spasm). See the following dilution table. Injection of this product with a sterile, 27-30/0.40-0.30mm needle does not necessarily require EMG monitoring. The recommended initial injection dose for the lateral part of the medial and lateral parts of the upper orbital iliac muscle of the upper eyelid iliac muscle is 1.25-2.5 U. If the eyebrows, the lateral aspect of the orbicularis and the upper facial area affect visual acuity, the injection site should also be increased at the corresponding site. Avoiding injections close to the upper eyelid side can reduce complications of drooping eyelids. Avoid the injection of the inside of the lower eyelid to reduce the spread of the oblique muscle, which can reduce the complications of double vision. The lower icon shows the injection reference site: it takes effect within three days after the general injection and reaches a peak in 1-2 weeks. Each treatment lasts for approximately 3 months and can be repeated as needed. When repeating treatment, if the initial therapeutic dose is considered insufficient, the injected dose can be increased or even doubled. However, if an injection site dose exceeds 5.0 U, there will be no better effect. The initial therapeutic dose per eye should not exceed 25U. In general, treatment frequencies greater than once every 3 months are not beneficial to the patient. When treating eyelids, the total dose per 12 weeks should not exceed 100U. Hemifacial spasm and VII pairs of patients with abnormal brain function, treatment of patients with unilateral orbital, and other affected facial muscles can be injected as needed. If the first treatment fails, ie one month after the injection, there is no significant clinical improvement compared to before treatment, the following measures should be taken: • Clinical validation, including specialists performing an EMG examination of the blockade of injected muscle; • Analysis failure Causes such as: improper selection of injected muscles, insufficient injection dose, lack of injection technique, occurrence of fixed muscle contracture, antagonism of muscle weakness, neutralization of toxin antibody formation, etc.; • Re-evaluation of treatment with Clostridium botulinum toxin type A; • If the first treatment is not effective, the following measures can be taken for the second treatment:
  (1) Analyze the cause of the first treatment failure and adjust the dose;
  (2) Injection under EMG monitoring;
  (3) There is a three-month interval between the two treatments. If the reinjection treatment fails or is not effective, consider replacing the treatment. How to use, handle and dispose of this product: It is recommended to carry out the dilution operation and the preparation of the syringe on the paper towel with plastic liner to prevent the liquid from splashing. The product was diluted with sterile, preservative-free saline (0.9% sodium chloride for injection). Draw the appropriate amount of diluent with a syringe (see the dilution table below). Since the product will be denatured by the vibration of bubbles or similar forces, the diluent should be gently pushed into the bottle. If there is no vacuum suction in the bottle, the bottle should be discarded. After preparation, this product should be a clear liquid with no color to slightly yellow and no impurities. Before using the preparation solution, visually check the clarity and impurities. The preparation solution should be stored in the refrigerator (2 ° C - 8 ° C) for up to 4 hours. This product can only be used in a single use, and the remaining solution should be discarded. For safety reasons, unused vials should be filled with a small amount of water and then autoclaved; all used vials, syringes, and spilled liquids should be autoclaved or 0.5% hypochlorous acid. The salt solution inactivated the residue of the product for 5 minutes.

  [Storage] Store at 2oC~8oC in cold storage or below -5oC. After preparation: Store at 2oC~8oC in cold storage and use within 4 hours. Container: A 10 ml capacity type I colorless glass bottle with a rubber stopper and sealed with aluminum foil.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Familial spastic paraplegia

  Tolterodine

  【Product name】Stock

  [English common name]Tolterodine

  [Chinese common name]Tolterodine

  [English name]

  [Chinese other name]

  [indications]
  Tolterodine tartrate tablets: This product is suitable forExcessive bladderExcitation caused by frequent urination, urgency or urgent urinary incontinence symptoms.
  Tolterodine Tartrate Capsule: This product is suitable for the treatment of urinary frequency, urgency or urgent urinary incontinence caused by excessive bladder excitement.
  Tolterodine tartrate sustained release capsule: This product is suitable for the treatment of urinary frequency, urgency or urgent urinary incontinence caused by excessive bladder excitement.

  【Dosage】
  Tolterodine tartrate tablets: The initial recommended dose is 1 tablet at a time, 2 times a day. Depending on the patient's response and tolerance, the dose can be adjusted down to one and a half tablets, twice a day. For patients with hepatic insufficiency or who are taking CYP3A4 inhibitors (see [Drug Interactions]), the recommended dose is one and a half tablets, twice a day.
  Tolterodine Tartrate Capsules: The maximum dose to volunteers is a single dose of 12.8 mg of tolterodine L-tartrate. The most serious adverse reaction is dysregulation and dysuria. In this event of excessive product, gastric lavage and activated carbon are used for treatment.
  Tolterodine tartrate sustained-release capsules: The initial recommended dose is 2 mg each time, twice daily. Depending on the patient's response and tolerance, the dose can be adjusted down to 1 mg each time, twice daily. For patients with hepatic insufficiency or who are taking CYP3A4 inhibitors (see drug interactions), the recommended dose is 1 mg each time, twice daily.

  [Storage]
  Tolterodine tartrate tablets: sealed, stored at room temperature (10 ~ 30 ° C).
  Tolterodine tartrate capsule: shading, confined preservation.
  Tolterodine tartrate sustained release capsule: 15-30 ° C protected from light.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  epilepsy , Lennox-Gastaut syndrome

  Lufinamide

  【Product name】BANZEL

  [English common name]Rufinamide

  [Chinese common name]Lufinamide

  [English name]

  [Chinese other name]

  Indications syndromeepilepsyAdjuvant therapy for seizures.

  [Usage and Dosage] Initially 400-800mg per day, increase by 400-800mg / day every other day, reaching the goal of 3200mg / day. Avoid sudden stops (25% reduction every 2 days).

  [Storage] Store tablets at 25 ° C (77 ° F); allow for offset 15 ° -30 ° C (59 ° F – 86 ° F). Moisture proof. Replace the cover after opening.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Lennox-Gastaut syndrome , Infant severe myoclonic epilepsy (Dravet syndrome)

  Sodium valproate

  【Product name】VALPROIC, Depacon

  [English common name]Sodium Valproate

  [Chinese common name]Sodium valproate

  [English name] sodium, 2-propylpentanoate

  [Chinese other name]Sodium 2-propylvalerate

  [indications]
  Sodium valproate tablets: mainly used for simple or complex absence seizures, myoclonic seizures, large seizures of single or combined medications, and sometimes have a certain effect on complex partial seizures.
  Sodium valproate syrup: This product is used for systemic, partial or other types.epilepsy.

  【Dosage】
  Sodium valproate tablets:
  Adults commonly used: daily weight 15mg / kg or 0.6-1.2g (3-6 tablets) per day 2-3 times. Start with 5-10mg/kg, and increase it after one week until it can control the seizure. When the daily dosage exceeds 250mg, it should be taken in divided doses to reduce gastrointestinal irritation. The maximum daily dose is no more than 30mg/kg by weight, or 1.8-2.4g (9-12 pieces) per day. Commonly used in children: the same as adults, can also be 20-30mg/kg per day, divided into 2-3 times or 15mg/kg per day, increase by 5-10mg/kg every other week, to be effective or not Tolerance.
  Sodium valproate syrup: Oral:
  1 Adult commonly used amount: daily weight 15mg/kg or 600~1200mg daily, in divided doses. At the beginning, the body weight is 5-10 mg/kg, and it increases after one week until the seizure is controlled. When the daily dosage exceeds 250mg, it should be taken in divided doses daily to reduce gastrointestinal irritation. The maximum amount is generally not more than 30 mg/kg per day, or 1.8 to 2.4 g per day.
  2 pediatric commonly used amount: the same as adults by weight. It has also been reported that at the beginning, the body weight is 15 mg/kg, and 5 to 10 mg/kg is added every other week as needed until it is effective or not tolerated.

  [Storage]
  Sodium valproate tablets: sealed and stored in a dry place.
  Sodium valproate syrup: shading, sealed, and kept in a cool dry place.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.